Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Cost of Revenue (2017 - 2020)

Historic Cost of Revenue for Ironwood Pharmaceuticals (IRWD) over the last 7 years, with Q4 2020 value amounting to $897000.0.

  • Ironwood Pharmaceuticals' Cost of Revenue fell 9185.51% to $897000.0 in Q4 2020 from the same period last year, while for Dec 2020 it was $3.1 million, marking a year-over-year decrease of 8686.49%. This contributed to the annual value of $3.1 million for FY2020, which is 8686.49% down from last year.
  • As of Q4 2020, Ironwood Pharmaceuticals' Cost of Revenue stood at $897000.0, which was down 9185.51% from $2.2 million recorded in Q1 2020.
  • In the past 5 years, Ironwood Pharmaceuticals' Cost of Revenue registered a high of $21.5 million during Q4 2018, and its lowest value of $506000.0 during Q3 2019.
  • Its 4-year average for Cost of Revenue is $5.6 million, with a median of $3.8 million in 2017.
  • Its Cost of Revenue has fluctuated over the past 5 years, first skyrocketed by 39096.05% in 2018, then crashed by 9185.51% in 2020.
  • Ironwood Pharmaceuticals' Cost of Revenue (Quarter) stood at $9.0 million in 2017, then surged by 138.9% to $21.5 million in 2018, then plummeted by 48.69% to $11.0 million in 2019, then crashed by 91.86% to $897000.0 in 2020.
  • Its Cost of Revenue stands at $897000.0 for Q4 2020, versus $2.2 million for Q1 2020 and $11.0 million for Q4 2019.